A large multicenter clinical trial led by King's College London with 150 children and adolescents has shown that a device cleared by the US FDA to treat ADHD is not effective in reducing symptoms.

In total, I spent about £2,000 on assessment and diagnosis. But I was holding out for the point at which I could move my care ...

Adults can have ADHD, often undiagnosed since childhood. Dr. Dania Antalaya explains symptoms, how adult diagnosis works, and ...

Last month, Southern Weekly reported on a policy at some hospitals in Shanxi requiring that ADHD patients get a "Class 1 Psychiatric Drug Prescribed" stamp in their hukou household registration ...

Lumos Labs has obtained a clearance from the FDA for its popular Lumosity brain training platform, greenlighting a version of it to be marketed as a prescription ...

SAN FRANCISCO--(BUSINESS WIRE)--Lumos Labs, creators of the popular Lumosity brain training platform with over 100 million users, announced today that the U.S. Food and Drug Administration (FDA) has ...

Lumos Labs, creators of the popular Lumosity brain training platform with over 100 million users, announced today that the U.S. Food and Drug Administration (FDA) has granted 510(k) clearance for ...

Findings showed patients receiving LumosityRx demonstrated a statistically significant improvement in TOVA ACS compared with sham treatment (P =.0149). The Food and Drug Administration (FDA) has ...

The most comprehensive review to date of ADHD treatments has found that medication for children and adults, and cognitive behavioral therapy for adults, remain the most effective approaches, backed by ...

David Coghill has received honoraria from Medice, Novartis, Takeda and Servier and royalties from Oxford University Press and Cambridge University Press. He receives research funding from the National ...

The signs were there but subtle. Dustin Chandler never did his homework. He was labeled lazy at school. It wasn’t until years later when his mother, now working at a pediatric clinic, watched him ...